Patents by Inventor Marc Heidl

Marc Heidl has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PURIFICATION OF SPECIFIC TRIPEPTIDE BY ACIDIFICATION
    Publication number: 20240254164
    Abstract: The present invention relates to purification of a tripeptide of formula (I). By using said method, the tripeptide of formula (I) is obtained in a very pure form and due to this effect the purified tripeptide can be used in a variety of cosmetic and pharmaceutic compositions which are not accessible for the respective unpurified tripeptide.
    Type: Application
    Filed: May 3, 2022
    Publication date: August 1, 2024
    Inventors: Marc HEIDL, Thomas SCHAERER, Alexander SCHLIFKE-POSCHALKO
  • PURIFICATION OF SPECIFIC TRIPEPTIDE BY USE OF ETHERS
    Publication number: 20240239839
    Abstract: The present invention relates to purification of a tripeptide of formula (I). By using said method, the tripeptide of formula (I) is obtained in a very pure form and due to this effect the purified tripeptide can be used in a variety of cosmetic and pharmaceutic compositions which are not accessible for the respective unpurified tripeptide.
    Type: Application
    Filed: May 3, 2022
    Publication date: July 18, 2024
    Inventors: Marc HEIDL, Thomas SCHAERER, Alexander SCHLIFKE-POSCHALKO
  • Methods for the synthesis of arginine-containing peptides
    Patent number: 11753440
    Abstract: Methods for the synthesis of arginine-containing peptides are provided. The methods include a deprotection step that minimizes the transfer of by-products deriving from cleaved sulfonyl-5 based side chain protecting groups from arginine to amino acids carrying electron rich side chains.
    Type: Grant
    Filed: June 5, 2019
    Date of Patent: September 12, 2023
    Assignee: DSM IP ASSETS B.V.
    Inventors: Marc Heidl, Piero Geotti-Bianchini
  • Melanocortin-1-receptor agonists
    Patent number: 11591367
    Abstract: The present invention relates to novel selective melanocortin-1 receptor (MC1R) agonists as well as the use thereof as skin tanning agents.
    Type: Grant
    Filed: October 2, 2017
    Date of Patent: February 28, 2023
    Assignee: DSM IP ASSETS B.V.
    Inventors: Marc Heidl, Eileen Jackson
  • Biaromatic compounds, which are vitamin D analogs
    Patent number: 11168054
    Abstract: Novel biaromatic compounds, which are vitamin D analogs, processes for their preparation and cosmetic, dermatological and pharmaceutical preparations containing one or more of these compounds.
    Type: Grant
    Filed: December 14, 2016
    Date of Patent: November 9, 2021
    Assignee: DSM IP ASSETS B.V.
    Inventors: Igor Bendik, Piero Geotti-Bianchini, Marc Heidl, Eileen Jackson, Alexander Schlifke-Poschalko
  • MELANOCORTIN-1-RECEPTOR AGONISTS
    Publication number: 20210277058
    Abstract: The present invention relates to novel selective melanocortin-1 receptor (MC1R) agonists as well as the use thereof as skin tanning agents.
    Type: Application
    Filed: October 2, 2017
    Publication date: September 9, 2021
    Inventors: Marc HEIDL, Eileen JACKSON
  • METHODS FOR THE SYNTHESIS OF ARGININE-CONTAINING PEPTIDES
    Publication number: 20210230220
    Abstract: Methods for the synthesis of arginine-containing peptides are provided. The methods include a deprotection step that minimizes the transfer of by-products deriving from cleaved sulfonyl-5 based side chain protecting groups from arginine to amino acids carrying electron rich side chains.
    Type: Application
    Filed: June 5, 2019
    Publication date: July 29, 2021
    Inventors: Marc HEIDL, Piero GEOTTI-BIANCHINI
  • Biaromatic vitamin D analogs
    Patent number: 10849838
    Abstract: Novel biaromatic compounds, which are vitamin D analogs, processes for their preparation and cosmetic, dermatological and pharmaceutical preparations containing one or more of these compounds.
    Type: Grant
    Filed: December 14, 2016
    Date of Patent: December 1, 2020
    Assignee: DSM IP ASSETS B.V.
    Inventors: Igor Bendik, Piero Geotti-Bianchini, Marc Heidl, Eileen Jackson, Alexander Schlifke-Poschalko
  • Compounds
    Patent number: 10836791
    Abstract: The present invention relates to novel compounds which effectively inhibit the melanin synthesis in human melanocytes and are thus suitable for the treatment of senile lentigines, for smoothening skin color irregularities and/or for lightening natural skin color.
    Type: Grant
    Filed: September 13, 2017
    Date of Patent: November 17, 2020
    Assignee: DSM IP ASSETS B.V.
    Inventors: Marc Heidl, Eileen Jackson
  • ANTIMICROBIAL TETRAPEPTIDES
    Publication number: 20200308222
    Abstract: The present invention relates to novel tetrapeptides as well as the use thereof as antimicrobial agents.
    Type: Application
    Filed: October 29, 2018
    Publication date: October 1, 2020
    Inventors: Marc HEIDL, Eileen JACKSON
  • BIAROMATIC VITAMIN D ANALOGS
    Publication number: 20200290960
    Abstract: Novel biaromatic compounds, which are vitamin D analogs, processes for their preparation and cosmetic, dermatological and pharmaceutical preparations containing one or more of these compounds.
    Type: Application
    Filed: December 14, 2016
    Publication date: September 17, 2020
    Inventors: Igor BENDIK, Piero GEOTTI-BIANCHINI, Marc HEIDL, Eileen JACKSON, Alexander SCHLIFKE-POSCHALKO
  • Compounds
    Patent number: 10570075
    Abstract: Novel biaromatic compounds, which are vitamin D analogs, processes for their preparation and cosmetic, dermatological and pharmaceutical preparations containing one or more of these compounds.
    Type: Grant
    Filed: December 14, 2016
    Date of Patent: February 25, 2020
    Assignee: DSM IP ASSETS B.V.
    Inventors: Igor Bendik, Piero Geotti-Bianchini, Marc Heidl, Eileen Jackson, Alexander Schlifke-Poschalko
  • Selective 11-beta-hydroxysteroid dehydrogenase type 1 inhibitors
    Patent number: 10550097
    Abstract: The present invention relates to novel selective 11-beta-hydroxysteroid dehydrogenase type 1 (11?-HSD1) inhibitors and the use thereof to prevent age-induced skin structure and function defects.
    Type: Grant
    Filed: July 7, 2016
    Date of Patent: February 4, 2020
    Assignee: DSM IP ASSETS B.V.
    Inventors: Stéphanie Boudon, Piero Geotti-Bianchini, Marc Heidl, Eileen Jackson, Alexander Schlifke-Poschalko
  • (R)-N-(adamantyl-2-yl)pyrrolidine-2-carboxamide derivatives for cosmetic use
    Patent number: 10470991
    Abstract: The present invention relates to novel selective 11-beta-hydroxysteroid dehydrogenase type 1 (11?-HSD1) inhibitors and the use thereof to prevent age-induced skin structure and function defects.
    Type: Grant
    Filed: December 9, 2016
    Date of Patent: November 12, 2019
    Assignee: DSM IP ASSETS B.V.
    Inventors: Stephanie Boudon, Marc Heidl, Eileen Jackson
  • BIAROMATIC VITAMIN D ANALOGS
    Publication number: 20190290563
    Abstract: Novel biaromatic compounds, which are vitamin D analogs, processes for their preparation and cosmetic, dermatological and pharmaceutical preparations containing one or more of these compounds.
    Type: Application
    Filed: December 14, 2016
    Publication date: September 26, 2019
    Inventors: Igor BENDIK, Piero GEOTTI-BIANCHINI, Marc HEIDL, Eileen JACKSON, Alexander SCHLIFKE-POSCHALKO
  • NOVEL COMPOUNDS
    Publication number: 20190263858
    Abstract: The present invention relates to novel compounds which effectively inhibit the melanin synthesis in human melanocytes and are thus suitable for the treatment of senile lentigines, for smoothening skin color irregularities and/or for lightening natural skin color.
    Type: Application
    Filed: September 13, 2017
    Publication date: August 29, 2019
    Inventors: Marc HEIDL, Eileen JACKSON
  • Biaromatic vitamin D analogs
    Patent number: 10336675
    Abstract: Novel biaromatic compounds, which are vitamin D analogs, processes for their preparation and cosmetic, dermatological and pharmaceutical preparations containing one or more of these compounds.
    Type: Grant
    Filed: December 14, 2016
    Date of Patent: July 2, 2019
    Assignee: DSM IP ASSETS B.V.
    Inventors: Igor Bendik, Piero Geotti-Bianchini, Marc Heidl, Eileen Jackson, Alexander Schlifke-Poschalko
  • BIAROMATIC VITAMIN D ANALOGS
    Publication number: 20190002378
    Abstract: Novel biaromatic compounds, which are vitamin D analogs, processes for their preparation and cosmetic, dermatological and pharmaceutical preparations containing one or more of these compounds.
    Type: Application
    Filed: December 14, 2016
    Publication date: January 3, 2019
    Inventors: Igor BENDIK, Piero GEOTTI-BIANCHINI, Marc HEIDL, Eileen JACKSON, Alexander SCHLIFKE-POSCHALKO
  • NOVEL COMPOUNDS
    Publication number: 20180362428
    Abstract: Novel biaromatic compounds, which are vitamin D analogs, processes for their preparation and cosmetic, dermatological and pharmaceutical preparations containing one or more of these compounds.
    Type: Application
    Filed: December 14, 2016
    Publication date: December 20, 2018
    Inventors: Igor BENDIK, Piero GEOTTI-BIANCHINI, Marc HEIDL, Eileen JACKSON, Alexander SCHLIFKE-POSCHALKO
  • (R)-N-(ADAMANTYL-2-YL)PYRROLIDINE-2-CARBOXAMIDE DERIVATIVES FOR COSMETIC USE
    Publication number: 20180344604
    Abstract: The present invention relates to novel selective 11-beta-hydroxysteroid dehydrogenase type 1 (11ß-HSD1) inhibitors and the use thereof to prevent age-induced skin structure and function defects.
    Type: Application
    Filed: December 9, 2016
    Publication date: December 6, 2018
    Inventors: Stephanie BOUDON, Marc HEIDL, Eileen JACKSON